• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[喹喔啉 1,4-二--氧化物的酯的抗活性]。

Anti- Activity of Esters of Quinoxaline 1,4-Di--Oxide.

机构信息

Unidad Académica Multidisciplinaria Reynosa-Rodhe, Universidad Autónoma de Tamaulipas, Carr. Reynosa-San Fernando, s/n, Reynosa 88779, Mexico.

Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México 11340, Mexico.

出版信息

Molecules. 2018 Jun 15;23(6):1453. doi: 10.3390/molecules23061453.

DOI:10.3390/molecules23061453
PMID:29914062
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6099706/
Abstract

Tuberculosis continues to be a public health problem in the world, and drug resistance has been a major obstacle in its treatment. Quinoxaline 1,4-di--oxide has been proposed as a scaffold to design new drugs to combat this disease. To examine the efficacy of this compound, this study evaluates methyl, ethyl, isopropyl, and n-propyl esters of quinoxaline 1,4-di--oxide derivatives in vitro against (pansusceptible and monoresistant strains). Additionally, the inhibitory effect of esters of quinoxaline 1,4-di--oxide on gyrase supercoiling was examined, and a stability analysis by ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS) was also carried out. Results showed that eight compounds (, , , , , , and ) had an activity similar to that of the reference drug isoniazid (minimum inhibitory concentration (MIC) = 0.12 µg/mL) with an effect on nonreplicative cells and drug monoresistant strains. Structural activity relationship analysis showed that the steric effect of an ester group at 7-position is key to enhancing its biological effects. Additionally, showed a high stability after 24 h in human plasma at 37 °C.

摘要

结核病仍然是全球公共卫生问题,耐药性是其治疗的主要障碍。喹喔啉 1,4-二氧化物已被提议作为设计新药物来对抗这种疾病的支架。为了研究该化合物的疗效,本研究评估了体外对 (泛敏感和单耐药株)的喹喔啉 1,4-二氧化物衍生物的甲酯、乙酯、异丙酯和正丙酯的抑制作用。此外,还研究了喹喔啉 1,4-二氧化物酯对拓扑异构酶超螺旋的抑制作用,并通过超高效液相色谱-串联质谱法(UPLC-MS)进行了稳定性分析。结果表明,有 8 种化合物( 、 、 、 、 、 、 )具有与参考药物异烟肼(最低抑菌浓度(MIC)=0.12 µg/mL)相似的活性,对非复制细胞和单耐药株均有作用。构效关系分析表明,7 位酯基的空间位阻是增强其生物学效应的关键。此外, 在 37°C 下,人血浆中 24 小时后具有较高的稳定性。

相似文献

1
Anti- Activity of Esters of Quinoxaline 1,4-Di--Oxide.[喹喔啉 1,4-二--氧化物的酯的抗活性]。
Molecules. 2018 Jun 15;23(6):1453. doi: 10.3390/molecules23061453.
2
Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents.喹喔啉 1,4-二氧化物衍生物作为抗结核药物的合成、3D-QSAR 分析及生物学评价
Bioorg Med Chem Lett. 2016 Aug 15;26(16):4146-53. doi: 10.1016/j.bmcl.2016.01.066. Epub 2016 Jan 22.
3
Synthesis of new 2-acetyl and 2-benzoyl quinoxaline 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents.新型2-乙酰基和2-苯甲酰基喹喔啉1,4-二氧化物衍生物作为抗结核分枝杆菌药物的合成
Eur J Med Chem. 2003 Sep;38(9):791-800. doi: 10.1016/s0223-5234(03)00137-5.
4
Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives.新型喹喔啉-2-甲酰胺 1,4-二-N-氧化物衍生物的合成及抗分枝杆菌活性。
Eur J Med Chem. 2010 Oct;45(10):4418-26. doi: 10.1016/j.ejmech.2010.06.036. Epub 2010 Jul 3.
5
New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents.新型 3-甲基喹喔啉-2-甲酰胺 1,4-二-N-氧化物衍生物作为抗结核分枝杆菌药物。
Bioorg Med Chem. 2010 Apr 1;18(7):2713-9. doi: 10.1016/j.bmc.2010.02.024. Epub 2010 Feb 20.
6
Anti-Mycobacterium tuberculosis agents derived from quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide.源自喹喔啉-2-甲腈和喹喔啉-2-甲腈1,4-二氧化物的抗结核分枝杆菌药物。
Arzneimittelforschung. 2002;52(2):113-9. doi: 10.1055/s-0031-1299866.
7
Efficacy of quinoxaline-2-carboxylate 1,4-di-N-oxide derivatives in experimental tuberculosis.喹喔啉-2-羧酸1,4-二氮氧化物衍生物在实验性结核病中的疗效
Antimicrob Agents Chemother. 2008 Sep;52(9):3321-6. doi: 10.1128/AAC.00379-08. Epub 2008 Jul 14.
8
Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides.新型喹喔啉 1,4 - 二氮氧化物对结核分枝杆菌的选择性活性。
Bioorg Med Chem. 2009 Jan 1;17(1):385-9. doi: 10.1016/j.bmc.2008.10.086. Epub 2008 Nov 5.
9
Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents.新型喹喔啉-2-羧酸1,4-二氧化物衍生物作为抗结核分枝杆菌药物的合成
J Med Chem. 2005 Mar 24;48(6):2019-25. doi: 10.1021/jm049952w.
10
In vitro antitubercular and antimicrobial activities of 1-substituted quinoxaline-2,3(1H,4H)-diones.1-取代喹喔啉-2,3(1H,4H)-二酮的体外抗结核和抗菌活性。
Bioorg Med Chem Lett. 2010 Jan 1;20(1):406-8. doi: 10.1016/j.bmcl.2009.10.026. Epub 2009 Oct 12.

引用本文的文献

1
Nifuroxazide and 4-Hydroxybenzhydrazone Derivatives as New Antiparasitic ( and ) and Anti- Agents.硝呋齐特和4-羟基苯腙衍生物作为新型抗寄生虫和抗菌剂。
Pharmaceutics. 2025 May 7;17(5):621. doi: 10.3390/pharmaceutics17050621.
2
In Vitro Evaluation of Esters of Quinoxaline-1,4-di-oxide Derivatives as New Antitaeniasis Agents and Their Inhibitory Activity Against Triosephosphate Isomerase.喹喔啉-1,4-二氧化物衍生物酯作为新型抗绦虫剂的体外评价及其对磷酸丙糖异构酶的抑制活性
Pharmaceuticals (Basel). 2025 Mar 13;18(3):406. doi: 10.3390/ph18030406.
3
Advances in antibacterial agents for .

本文引用的文献

1
Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity.具有体内杀菌抗结核活性的含氮氧化物杂环的设计、合成与表征
J Med Chem. 2017 Oct 26;60(20):8647-8660. doi: 10.1021/acs.jmedchem.7b01332. Epub 2017 Oct 16.
2
Trypanocidal Activity of Quinoxaline 1,4 Di-N-oxide Derivatives as Trypanothione Reductase Inhibitors.喹喔啉 1,4-二氧化物衍生物作为锥虫硫氧还蛋白还原酶抑制剂的杀锥虫活性
Molecules. 2017 Feb 1;22(2):220. doi: 10.3390/molecules22020220.
3
Current perspectives in drug discovery against tuberculosis from natural products.
用于……的抗菌剂的进展
RSC Med Chem. 2024 Oct 18;16(1):37-49. doi: 10.1039/d4md00508b.
4
Quinoxaline 1,4-di--oxide Derivatives as New Antinocardial Agents.喹喔啉 1,4-二氧化物衍生物作为新型抗心肌药物。
Molecules. 2024 Sep 30;29(19):4652. doi: 10.3390/molecules29194652.
5
Expanding the chemical space of ester of quinoxaline-7-carboxylate 1,4-di--oxide derivatives as potential antitubercular agents.拓展喹喔啉-7-羧酸酯1,4-二氧化物衍生物作为潜在抗结核药物的化学空间。
RSC Med Chem. 2024 Jul 17;15(8):2785-2791. doi: 10.1039/d4md00221k. eCollection 2024 Aug 14.
6
In Vitro and In Silico Analysis of New n-Butyl and Isobutyl Quinoxaline-7-carboxylate 1,4-di--oxide Derivatives against as Trypanothione Reductase Inhibitors.新型 n-丁基和异丁基喹喔啉-7-羧酸 1,4-二--氧化物衍生物抗 作为 硫醇还原酶抑制剂的体外和计算分析。
Int J Mol Sci. 2022 Nov 1;23(21):13315. doi: 10.3390/ijms232113315.
7
Quinoxaline Moiety: A Potential Scaffold against .喹喔啉部分:一种潜在的针对. 的支架。
Molecules. 2021 Aug 5;26(16):4742. doi: 10.3390/molecules26164742.
8
Organic synthesis and anti-influenza A virus activity of cyclobakuchiols A, B, C, and D.环巴库醇A、B、C和D的有机合成及抗甲型流感病毒活性
PLoS One. 2021 Mar 26;16(3):e0248960. doi: 10.1371/journal.pone.0248960. eCollection 2021.
9
-Pyrazinoyl Substituted Amino Acids as Potential Antimycobacterial Agents-The Synthesis and Biological Evaluation of Enantiomers.-吡嗪甲酰基取代的氨基酸作为潜在的抗分枝杆菌药物-对映异构体的合成与生物学评价。
Molecules. 2020 Mar 27;25(7):1518. doi: 10.3390/molecules25071518.
天然产物抗结核药物研发的当前观点
Int J Mycobacteriol. 2015 Sep;4(3):165-83. doi: 10.1016/j.ijmyco.2015.05.004. Epub 2015 Jun 3.
4
Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents.喹喔啉 1,4-二氧化物衍生物作为抗结核药物的合成、3D-QSAR 分析及生物学评价
Bioorg Med Chem Lett. 2016 Aug 15;26(16):4146-53. doi: 10.1016/j.bmcl.2016.01.066. Epub 2016 Jan 22.
5
Ester of Quinoxaline-7-carboxylate 1,4-di-N-oxide as Apoptosis Inductors in K-562 Cell Line: An in vitro, QSAR and DFT Study.喹喔啉-7-羧酸1,4-二氮氧化物酯作为K-562细胞系中的凋亡诱导剂:一项体外、定量构效关系和密度泛函理论研究
Anticancer Agents Med Chem. 2017;17(5):682-691. doi: 10.2174/1871520616666160630175927.
6
New Conjugates of Quinoxaline as Potent Antitubercular and Antibacterial Agents.作为强效抗结核和抗菌剂的喹喔啉新共轭物。
Int J Med Chem. 2016;2016:6471352. doi: 10.1155/2016/6471352. Epub 2016 Mar 8.
7
Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis.结核分枝杆菌中gyrase-氟喹诺酮切割复合物的晶体结构与稳定性
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1706-13. doi: 10.1073/pnas.1525047113. Epub 2016 Jan 20.
8
Multidrug-resistant tuberculosis around the world: what progress has been made?全球耐多药结核病:取得了哪些进展?
Eur Respir J. 2015 Jan;45(1):150-60. doi: 10.1183/09031936.00101814. Epub 2014 Sep 26.
9
Present status of quinoxaline motifs: excellent pathfinders in therapeutic medicine.喹喔啉基序的现状:治疗医学中的优秀探索者。
Eur J Med Chem. 2014 Oct 6;85:688-715. doi: 10.1016/j.ejmech.2014.08.034. Epub 2014 Aug 10.
10
Anti-Trypanosoma cruzi and anti-leishmanial activity by quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives.喹喔啉-7-羧酸1,4-二氮氧化物衍生物的抗克氏锥虫和抗利什曼原虫活性
Parasitol Res. 2014 Jun;113(6):2027-35. doi: 10.1007/s00436-014-3850-8. Epub 2014 Apr 2.